Valuation: IRADIMED CORPORATION

Market Cap 110.72Cr 100Cr 92Cr 83Cr 157.68Cr 10TCr 161.57Cr 1.1TCr 440.39Cr 5.56TCr 415.53Cr 406.7Cr 18TCr P/E 2026 *
45.3x
P/E 2027 * 38.8x
Enterprise Value 110.72Cr 100Cr 92Cr 83Cr 157.68Cr 10TCr 161.57Cr 1.1TCr 440.39Cr 5.56TCr 415.53Cr 406.7Cr 18TCr EV / Sales 2026 *
12x
EV / Sales 2027 * 10.8x
Free-Float
64.82%
Yield 2026 *
-
Yield 2027 * -
1 day-0.30%
1 week+0.70%
Current month+12.34%
1 month-3.72%
3 months-1.44%
6 months+1.64%
Current year-11.45%
1 week 83.31
Extreme 83.31
87.97
1 month 76.35
Extreme 76.35
91.05
Current year 76.35
Extreme 76.35
107.9
1 year 76.35
Extreme 76.35
107.9
3 years 39.24
Extreme 39.24
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Exercice

Director

1,396 0.0109%
03/09/26 Sell

Director

-1,419 0.0111%
04/06/26 Sell

Director

-3,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%+0.70%-0.34%+106.72% 110.72Cr
-2.15%+3.62%+19.29%+57.57% 27TCr
-0.19%+3.41%+6.68%+19.43% 17TCr
-1.41%-5.77%-22.88%+56.29% 16TCr
-2.26%-1.55%-57.79%-18.17% 6.54TCr
-0.05%+4.70%+23.35%+63.41% 6.08TCr
+0.83%-2.53%-2.14%-7.51% 5.37TCr
-1.93%+0.70%+14.16%+60.97% 4.99TCr
-1.72%-3.41%+0.87%+80.17% 4.93TCr
-0.83%+2.67%+20.09%+85.34% 4.63TCr
Average -1.02%+0.54%+0.13%+50.42% 9TCr
Weighted average by Cap. -1.27%-0.38%+2.05%+44.46%

Financials

2026 *2027 *
Net sales 9.22Cr 8.31Cr 7.68Cr 6.94Cr 13Cr 864.75Cr 13Cr 92Cr 37Cr 463.13Cr 35Cr 34Cr 1.47TCr 10Cr 9.22Cr 8.52Cr 7.7Cr 15Cr 959.79Cr 15Cr 102.12Cr 41Cr 514.03Cr 38Cr 38Cr 1.64TCr
Net income 2.46Cr 2.21Cr 2.05Cr 1.85Cr 3.5Cr 230.41Cr 3.59Cr 25Cr 9.77Cr 123.4Cr 9.22Cr 9.02Cr 392.7Cr 2.88Cr 2.6Cr 2.4Cr 2.17Cr 4.1Cr 270.12Cr 4.2Cr 29Cr 11Cr 144.67Cr 11Cr 11Cr 460.37Cr
Net Debt - -
Projected Income Statement - Annual - IRADIMED CORPORATION
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
12/26/12 $86.14 -0.51% 18,307
11/26/11 $86.58 -0.16% 79,774
10/26/10 $86.72 -0.25% 1,29,206
09/26/09 $86.94 +0.73% 1,02,586
06/26/06 $86.31 +0.90% 2,22,103
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - IRADIMED CORPORATION
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
86.58USD
Average target price
118.00USD
Spread / Average Target
+36.29%
  1. Stock Market
  2. Stocks
  3. IRMD Stock